The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA
The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster
Join us as we raise awareness of the medical lab profession with a global one day publishing event
Collaboration to advance newborn genetic screening, leveraging cutting-edge genomics research and laboratory expertise to detect rare conditions early
Patient blood management experts share how nuanced approaches beyond following hemoglobin thresholds can help lead to better patient outcomes
The latest solution to enable comprehensive genomic profiling of tumors was presented at the annual meeting of the Association of Molecular Pathology
GERSTEL joins AAT’s portfolio of leading brands, including Skalar Analytical, LCTech, PromoChrom, EST Analytical, and tsHR, boosting global reach and expanding product and service offerings
